Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.110
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.160
+0.050 (4.50%)
After-hours: Mar 9, 2026, 6:18 PM EDT

Sunshine Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
56714305
Upgrade
Market Cap Growth
10.25%-13.95%-51.77%-52.26%480.17%1941.74%
Upgrade
Enterprise Value
-3-6-11-26326
Upgrade
Last Close Price
1.113.00543.001280.0023380.006280.00
Upgrade
PS Ratio
0.150.170.293.33132.5573.08
Upgrade
PB Ratio
0.210.260.330.67143.04-5.47
Upgrade
P/TBV Ratio
0.250.290.350.69271.15-
Upgrade
EV/Sales Ratio
----137.9881.76
Upgrade
Debt / Equity Ratio
0.040.040.030.048.98-2.00
Upgrade
Net Debt / Equity Ratio
-0.35-0.37-0.74-0.97-0.72-0.96
Upgrade
Net Debt / EBITDA Ratio
1.851.563.372.440.06-1.63
Upgrade
Net Debt / FCF Ratio
1.140.621.773.870.08-1.39
Upgrade
Asset Turnover
1.211.200.850.280.140.13
Upgrade
Inventory Turnover
2.092.853.491.561.821.30
Upgrade
Quick Ratio
2.022.153.393.4322.590.95
Upgrade
Current Ratio
4.214.114.483.9424.070.98
Upgrade
Return on Equity (ROE)
-24.34%-22.97%-21.04%-244.92%--
Upgrade
Return on Assets (ROA)
-9.87%-12.55%-10.57%-34.48%-93.90%-63.05%
Upgrade
Return on Capital Employed (ROCE)
-19.60%-24.00%-22.00%-38.90%-115.60%9893.20%
Upgrade
Earnings Yield
-110.05%-85.58%-64.63%-185.03%-41.08%-53.35%
Upgrade
FCF Yield
-135.98%-236.51%-127.05%-37.65%-6.04%-12.62%
Upgrade
Buyback Yield / Dilution
-1977.26%-5371.73%----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.